150 related articles for article (PubMed ID: 34871415)
1. Pneumonectomy for primary lung cancer: contemporary outcomes, risk factors and model validation.
Brunswicker A; Taylor M; Grant SW; Abah U; Smith M; Shackcloth M; Granato F; Shah R; Rammohan K;
Interact Cardiovasc Thorac Surg; 2022 Jun; 34(6):1054-1061. PubMed ID: 34871415
[TBL] [Abstract][Full Text] [Related]
2. Pneumonectomy: calculable or non-tolerable risk factor in trimodal therapy for Stage III non-small-cell lung cancer?
Steger V; Spengler W; Hetzel J; Veit S; Walker T; Mustafi M; Friedel G; Walles T
Eur J Cardiothorac Surg; 2012 Apr; 41(4):880-5; discussion 885. PubMed ID: 22233799
[TBL] [Abstract][Full Text] [Related]
3. Pneumonectomy for Clinical Stage IIIA Non-Small Cell Lung Cancer: The Effect of Neoadjuvant Therapy.
Broderick SR; Patel AP; Crabtree TD; Bell JM; Morgansztern D; Robinson CG; Kreisel D; Krupnick AS; Patterson GA; Meyers BF; Puri V
Ann Thorac Surg; 2016 Feb; 101(2):451-7; discussion 457-8. PubMed ID: 26410162
[TBL] [Abstract][Full Text] [Related]
4. Fate of Pneumonectomy Patients Variably Captured by Non-Small Cell Lung Cancer Staging System.
Dhanasopon AP; Salazar MC; Hoag JR; Rosen JE; Kim AW; Detterbeck FC; Blasberg JD; Boffa DJ
Ann Thorac Surg; 2017 Dec; 104(6):1829-1836. PubMed ID: 29074151
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of neoadjuvant concurrent chemoradiotherapy followed by surgery for non-small-cell lung cancer with N2 disease.
Kim HK; Cho JH; Choi YS; Zo JI; Shim YM; Park K; Ahn MJ; Ahn YC; Kim K; Kim J
Lung Cancer; 2016 Jun; 96():56-62. PubMed ID: 27133751
[TBL] [Abstract][Full Text] [Related]
6. Sleeve lobectomy for non-small cell lung cancer with N1 nodal disease does not compromise survival.
Berry MF; Worni M; Wang X; Harpole DH; D'Amico TA; Onaitis MW
Ann Thorac Surg; 2014 Jan; 97(1):230-5. PubMed ID: 24206972
[TBL] [Abstract][Full Text] [Related]
7. Effect of thoracic surgery regionalization on long-term survival after lung cancer resection.
Ely S; Jiang SF; Dominguez DA; Patel AR; Ashiku SK; Velotta JB
J Thorac Cardiovasc Surg; 2022 Mar; 163(3):769-777. PubMed ID: 33934900
[TBL] [Abstract][Full Text] [Related]
8. Pneumonectomy for lung cancer: contemporary national early morbidity and mortality outcomes.
Thomas PA; Berbis J; Baste JM; Le Pimpec-Barthes F; Tronc F; Falcoz PE; Dahan M; Loundou A;
J Thorac Cardiovasc Surg; 2015 Jan; 149(1):73-82. PubMed ID: 25439468
[TBL] [Abstract][Full Text] [Related]
9. Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer.
Weder W; Collaud S; Eberhardt WE; Hillinger S; Welter S; Stahel R; Stamatis G
J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1424-30. PubMed ID: 20416887
[TBL] [Abstract][Full Text] [Related]
10. Thoracoscopic lobectomy is associated with improved short-term and equivalent oncological outcomes compared with open lobectomy for clinical Stage I non-small-cell lung cancer: a propensity-matched analysis of 963 cases.
Stephens N; Rice D; Correa A; Hoffstetter W; Mehran R; Roth J; Walsh G; Vaporciyan A; Swisher S
Eur J Cardiothorac Surg; 2014 Oct; 46(4):607-13. PubMed ID: 24603446
[TBL] [Abstract][Full Text] [Related]
11. Risk of pneumonectomy after induction therapy for locally advanced non-small cell lung cancer.
d'Amato TA; Ashrafi AS; Schuchert MJ; Alshehab DS; Seely AJ; Shamji FM; Maziak DE; Sundaresan SR; Ferson PF; Luketich JD; Landreneau RJ
Ann Thorac Surg; 2009 Oct; 88(4):1079-85. PubMed ID: 19766784
[TBL] [Abstract][Full Text] [Related]
12. Right-Sided Versus Left-Sided Pneumonectomy After Induction Therapy for Non-Small Cell Lung Cancer.
Yang CJ; Shah SA; Lin BK; VanDusen KW; Chan DY; Tan WD; Ranney DN; Cox ML; D'Amico TA; Berry MF
Ann Thorac Surg; 2019 Apr; 107(4):1074-1081. PubMed ID: 30448482
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival following open versus thoracoscopic lobectomy after preoperative chemotherapy for non-small cell lung cancer.
Yang CF; Meyerhoff RR; Mayne NR; Singhapricha T; Toomey CB; Speicher PJ; Hartwig MG; Tong BC; Onaitis MW; Harpole DH; D'Amico TA; Berry MF
Eur J Cardiothorac Surg; 2016 Jun; 49(6):1615-23. PubMed ID: 26719408
[TBL] [Abstract][Full Text] [Related]
14. Pneumonectomy: risk factor or innocent bystander?
Warwick R; Mediratta N; Shackcloth M; Page R; McShane J; Shaw M; Poullis M
Asian Cardiovasc Thorac Ann; 2014 Jan; 22(1):49-54. PubMed ID: 24585644
[TBL] [Abstract][Full Text] [Related]
15. The impact of preoperative body mass index on respiratory complications after pneumonectomy for non-small-cell lung cancer. Results from a series of 154 consecutive standard pneumonectomies.
Petrella F; Radice D; Borri A; Galetta D; Gasparri R; Solli P; Veronesi G; Spaggiari L
Eur J Cardiothorac Surg; 2011 May; 39(5):738-44. PubMed ID: 20952203
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of the VA Lung Cancer Mortality (VALCAN-M) Score for 90-Day Mortality Following Surgical Treatment of Clinical Stage I Lung Cancer.
Heiden BT; Eaton DB; Brandt WS; Chang SH; Yan Y; Schoen MW; Patel MR; Kreisel D; Nava RG; Meyers BF; Kozower BD; Puri V
Ann Surg; 2023 Sep; 278(3):e634-e640. PubMed ID: 36250678
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes after nonintubated versus intubated thoracoscopic lobectomy for clinical stage I non-small cell lung cancer: A propensity-matched analysis.
Wang ML; How CH; Hung MH; Huang HH; Hsu HH; Cheng YJ; Chen JS
J Formos Med Assoc; 2021 Nov; 120(11):1949-1956. PubMed ID: 33994233
[TBL] [Abstract][Full Text] [Related]
18. Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly.
Shirvani SM; Jiang J; Chang JY; Welsh J; Likhacheva A; Buchholz TA; Swisher SG; Smith BD
JAMA Surg; 2014 Dec; 149(12):1244-53. PubMed ID: 25321323
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Long-term Survival of Patients With Early-Stage Non-Small Cell Lung Cancer After Surgery vs Stereotactic Body Radiotherapy.
Chi A; Fang W; Sun Y; Wen S
JAMA Netw Open; 2019 Nov; 2(11):e1915724. PubMed ID: 31747032
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.
Uhlig J; Case MD; Blasberg JD; Boffa DJ; Chiang A; Gettinger SN; Kim HS
JAMA Netw Open; 2019 Aug; 2(8):e199702. PubMed ID: 31433481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
